Dr Morten Albrechtsen This is Me

 View all 16 references Web References

1. 1. CHDI Selects ENKAM’s Compounds for Preclinical Testing

   www.hdlighthouse.org/research/ - [Cached]

   Published on: 12/4/2006   Last Visited: 7/19/2008

   Adding to this comment, Morten Albrechtsen MD, Chief Executive and a co-founder of ENKAM Pharmaceuticals, said:"We are delighted to work together with CHDI and High Q to advance therapies for treatment of Huntington's disease."# # #

2. 2. www.hdac.org

   www.hdac.org/features/article. - [Cached]

   Published on: 12/4/2006   Last Visited: 3/31/2007

   Adding to this comment, Morten Albrechtsen MD, Chief Executive and a co-founder of ENKAM Pharmaceuticals, said:"We are delighted to work together with CHDI and High Q to advance therapies for treatment of Huntington's disease."

3. 3. Ageless Design, Alzheimers Daily News Service

   www.agelessdesign.com/news-alz - [Cached]

   Published on: 1/3/2004   Last Visited: 11/3/2004

   Morten Albrechtsen, CEO of ENKAM Pharmaceuticals (one of 18 research teams involved in the consortium), explained that the optimal drug to treat Alzheimer's disease has to fulfil three criteria.